ITEMS IN AFP WITH KEYWORD:
Stroke and TIA
Apr 1, 2010 Issue
Effectiveness of B-Complex Vitamins for Prevention of Cardiovascular Events [Cochrane for Clinicians]
Eight randomized clinical trials that included 24,210 patients did not show a reduction in MI, stroke, or all-cause mortality with B-complex vitamin therapy.
Does telmisartan therapy after stroke prevent recurrence and adverse cardiovascular events? Despite lowering blood pressure, telmisartan did not provide preventative benefit. This study reflects problems with publication bias and that surrogate markers, such as blood pressure control, may not reflect patient outcomes.
Stroke can be categorized as ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. Awakening with or experiencing the abrupt onset of focal neurologic deficits is the hallmark of ischemic stroke diagnosis. The most common presenting symptoms for ischemic stroke are difficulty with ...
Case study: K.A. is a 63-year-old man who presents for a routine wellness examination. His blood pressure and cholesterol level are within normal limits, and he has no history of tobacco use or heart disease.
Jun 15, 2008 Issue
Predicting Prognoses in Patients with Acute Stroke [Point-of-Care Guides]
A number of clinical decision models and scoring systems have been developed and validated to assist physicians in assessing the prognosis of patients with acute stroke.
Compared with antiplatelet therapy, oral anticoagulation significantly reduces stroke at an average follow-up of one to three years, but does not reduce mortality. Intracranial or extracranial hemorrhage is more common with anticoagulation and must be weighed against its therapeutic benefit.
Apr 1, 2008 Issue
Screening for Carotid Artery Stenosis: Recommendation Statement [U.S. Preventive Services Task Force]
This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on screening for carotid artery stenosis and the supporting scientific evidence, and updates the 1996 recommendations contained in the Guide to Clinical Preventive Services, 2nd ed.
Does the widespread use of the thrombolytic tissue plasminogen activator (t-PA) more beneficial or harmful in patients with acute stroke? The benefits must be balanced against the harms. Informed consent is necessary when making the decision.
Recurrent ischemic stroke and transient ischemic attack are common problems in primary care, with stroke survivors averaging 10 outpatient visits per year. Risk factors such as hypertension, diabetes, and hypercholesterolemia should be evaluated during each office visit. Attention should be given to...
Jun 1, 2007 Issue
Occupational Therapy Improves Activities of Daily Living After Stroke [Cochrane for Clinicians]
Compared with standard rehabilitation, ADL-based occupational therapy significantly decreases death or institutionalization and deterioration in the ability to perform ADL after stroke. The optimal length and type of therapy is not well defined.